Literature DB >> 34964776

Identification of FOXG1 mutations in infantile hypotonia and postnatal microcephaly.

Han Na Jang1, Taeho Kim2, Ah Young Jung3, Beom Hee Lee1, Mi-Sun Yum1, Tae-Sung Ko1.   

Abstract

ABSTRACT: FOXG1, located at chromosome 14q12, is critical for brain development, and patients with FOXG1 mutation exhibit developmental encephalopathy with high phenotypic variability, known as FOXG1 syndrome. Here, we report 3 cases of FOXG1 syndrome that presented with infantile hypotonia and microcephaly.A total of 145 children with developmental delay and/or hypotonia were evaluated by whole-exome sequencing (WES) in the pediatric neurology clinic and medical genetics center at Asan Medical Center Children's Hospital, from 2017 to 2019. Each FOXG1 mutation was confirmed by Sanger sequencing. The clinical findings of each patient with FOXG1 mutation were reviewed.WES identified de-novo, pathogenic, and heterozygous FOXG1 mutations in 3 of 145 patients in our patient cohort with developmental delay and/or hypotonia. The characteristics of brain magnetic resonance imaging (MRI) were reported as callosal anomaly, decrease in frontal volume, fornix thickening, and hypoplastic olfactory bulbs. A phenotype-genotype correlation was demonstrated as a patient with a novel missense mutation, c.761A > C (p.Tyr254Ser), in the forkhead domain had better outcome and milder brain abnormalities than the other 2 patients with truncating mutation in the Groucho binding domain site, c.958delC (p.Arg320Alafs), or N-terminal domain, c.506dup (p.Lys170GlnfsThe). Importantly, all 3 patients had hypoplastic olfactory bulbs on their brain MRI, which is a distinct and previously unrecognized feature of FOXG1 syndrome.This is the first report of FOXG1 syndrome in a Korean population; this condition accounts for 2% (3 of 145 patients) of our patient cohort with developmental delays and/or hypotonia. Our report contributes to understanding this extremely rare genetic condition in the clinical and genetic perspectives.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34964776      PMCID: PMC8615421          DOI: 10.1097/MD.0000000000027949

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

FOXG1 is a transcription repression factor involved in the development of the telencephalon by differentiating cortical compartments.[ After the first report in 2005 of a patient with a congenital variant of Rett syndrome due to a FOXG1 mutation,[ known as FOXG1 syndrome, over 170 affected cases have been reported.[ Compared to patients with classical Rett syndrome, patients with FOXG1 syndrome are more severely affected in terms of receptive language and social interactions, and they are likely unable to walk and exhibit dyskinetic-hyperkinetic movement, seizures, irritability sleep disturbance. Interestingly, in contrast to Rett syndrome, FOXG1 syndrome can affect both female and male and patients do not experience developmental regression.[ It is now considered that individuals harboring mutations in FOXG1 belong to a distinct clinical entity, termed “FOXG1 syndrome”. It is a condition characterized by early onset movement disorders, absent language, autistic features, epilepsy, intellectual disability, and structural brain abnormalities.[ In the current report, we describe 3 Korean children with FOXG1 syndrome, which was diagnosed by whole exome sequencing (WES). Our report further aids in understanding this extremely rare genetic condition.

Patients and methods

Totally, 145 children with developmental delay and/or hypotonia were evaluated by WES in the pediatric neurology clinic and medical genetics center at Asan Medical Center Children's Hospital, Seoul, Korea, from 2017 to 2019. Genomic DNA was isolated from either whole blood or saliva. All exons of all human genes (approximately 22,000) were captured using a SureSelect kit (Version C2; Agilent Technologies, Inc., Santa Clara, CA, USA) and sequenced using a NovaSeq platform (Illumina, San Diego, CA, USA). Raw genome sequences were aligned to the reference sequence (NCBI genome assembly GRCh37; accessed in February 2009). Each of the FOXG1 mutations was confirmed by Sanger sequencing. WES was performed as previously described,[ and each FOXG1 mutation was confirmed by Sanger sequencing. The clinical findings of each patient were reviewed. The parents of all patients provided written informed consent for the study, approved by the Medical Sciences Ethics Committee (IRB number 2017-0988).

Results

We found that FOXG1 mutation is accounted for 2% (3 of 145 patients) in our pediatric patients with developmental delay and/or hypotonia. Each patient's characteristics and clinical outcomes were described as below.

Case 1

This female infant was the second child of non-consanguineous Korean parents. Her birth was uneventful after 40 weeks of gestation. At 11 months of age, her head circumference (HC) was 42 cm ( C (p.Tyr254Ser) (Fig. 2A). Her parents did not carry the mutation.
Figure 1

MRI findings of patients with FOXG1-related syndromes. Case 1 MRI obtained at 13 months of age. The lateral ventricles are mildly enlarged on the T2W axial images of the brain (A, B), and the bilateral olfactory bulbs appear small (white arrows) on the T2W coronal image (C). Sagittal T1-weighted MRI of the brain shows mild thinning of the corpus callosum (D). Case 2 MRI obtained at 6 months of age. The fronto-temporal lobes and the bilateral basal ganglia appear slightly small (E), the fornices appear enlarged and separated (yellow arrows, F), and the olfactory bulbs appear slightly small (white arrows, G). Sagittal T1W image displays the dysgenetic corpus callosum with absent rostrum and thinning of the posterior body and splenium (H). Case 3 MRI obtained at 7 months of age. The fronto-temporal lobes and the bilateral basal ganglia appear slightly small with suspicious slightly simplified gyral pattern (I, J), and the fornices appear enlarged and separated (yellow arrows, J). The ventricles are not dilated, but there is prominence in the extra-axial CSF (J), and the olfactory bulbs appear hypoplastic (white arrows, K). Sagittal T1W image displays the dysgenetic corpus callosum with absent rostrum and overall thinning especially of the posterior body and splenium (L).

Figure 2

Sequence tracing of FOXG1 mutations and pedigree of each patient. These figures reveal sequence tracing of the FOXG1 mutations in each of the 3 patients. Case 1 patient with a novel missense mutation in the forkhead domain, c.761A > C (p.Tyr254Ser) (A), Case 2 patient with a truncating mutation in the GBD site, c.958delC (p.Arg320Alafs) (B) and Case 3 patient had truncating mutation at or N-terminal domain, c.506dup (p.Lys170Glnfs) (C). Mutated bases are indicated by black arrows above the line. GBD = Groucho binding domain.

MRI findings of patients with FOXG1-related syndromes. Case 1 MRI obtained at 13 months of age. The lateral ventricles are mildly enlarged on the T2W axial images of the brain (A, B), and the bilateral olfactory bulbs appear small (white arrows) on the T2W coronal image (C). Sagittal T1-weighted MRI of the brain shows mild thinning of the corpus callosum (D). Case 2 MRI obtained at 6 months of age. The fronto-temporal lobes and the bilateral basal ganglia appear slightly small (E), the fornices appear enlarged and separated (yellow arrows, F), and the olfactory bulbs appear slightly small (white arrows, G). Sagittal T1W image displays the dysgenetic corpus callosum with absent rostrum and thinning of the posterior body and splenium (H). Case 3 MRI obtained at 7 months of age. The fronto-temporal lobes and the bilateral basal ganglia appear slightly small with suspicious slightly simplified gyral pattern (I, J), and the fornices appear enlarged and separated (yellow arrows, J). The ventricles are not dilated, but there is prominence in the extra-axial CSF (J), and the olfactory bulbs appear hypoplastic (white arrows, K). Sagittal T1W image displays the dysgenetic corpus callosum with absent rostrum and overall thinning especially of the posterior body and splenium (L). Sequence tracing of FOXG1 mutations and pedigree of each patient. These figures reveal sequence tracing of the FOXG1 mutations in each of the 3 patients. Case 1 patient with a novel missense mutation in the forkhead domain, c.761A > C (p.Tyr254Ser) (A), Case 2 patient with a truncating mutation in the GBD site, c.958delC (p.Arg320Alafs) (B) and Case 3 patient had truncating mutation at or N-terminal domain, c.506dup (p.Lys170Glnfs) (C). Mutated bases are indicated by black arrows above the line. GBD = Groucho binding domain. At her latest visit at the age of 4.6 years, microcephaly (HC: 46.5 cm,

Case 2

This female infant was the first child of healthy non-consanguineous Korean parents. At 7 months of age, motor developmental delay and microcephaly (HC: 40 cm, WES revealed a pathogenic,[ frameshift FOXG1 mutation, c.958delC (p.Arg320Alafs), near the Groucho binding domain, which her parents did not carry (Fig. 2B). At latest follow-up at age of 1.6 years, microcephaly was persistent, and she could not sit without support and speak any meaningful word.

Case 3

This male infant was the second child of non-consanguineous Korean parents. His pre- and perinatal periods were uneventful. At the age of 6 months, he showed microcephaly (HC: 40 cm,
Figure 3

Serial EEG findings of the case 3 patient. The background activities consisted of high amplitude delta activities intermixed with sleep spindle activities at 13 months of age (A). The background activities consisted of high amplitude slow activities, concomitantly with high amplitude spikes or polyspikes and slow discharges over the left parieto-occipital areas or less from the left fronto-central areas at 51 months of age (B).

Serial EEG findings of the case 3 patient. The background activities consisted of high amplitude delta activities intermixed with sleep spindle activities at 13 months of age (A). The background activities consisted of high amplitude slow activities, concomitantly with high amplitude spikes or polyspikes and slow discharges over the left parieto-occipital areas or less from the left fronto-central areas at 51 months of age (B).

Discussion

In the current report, we describe 3 patients with infantile hypotonia and postnatal microcephaly, who were shown to have a de novo FOXG1 mutation by WES. This is the first report of FOXG1 syndrome in a Korean population, and 1 novel missense mutation was found. FOXG1, as a transcriptional repressor, is essential for forebrain development, including the cerebral cortex, hippocampus, and basal ganglia, which are derived from the telencephalon.[ The previous studies reported the major clinical features of FOXG1 syndrome as postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum anomaly.[ Patients with FOXG1 syndrome can also be affected by variable types of movement disorders and epilepsy.[ In addition, abnormal sleep patterns, irritability, and gastrointestinal symptoms have been observed in some patients.[ Since clinical features vary among patients, characteristics determined from brain MRI findings provide important clues for diagnosis, such as filiform thinning of the corpus callosum rostrum, gyral malformation, and thickened fornix.[ Our 3 study patients with FOXG1 syndrome also manifested with axial hypotonia during infancy and postnatally developed microcephaly with normal somatic growth; however, at presentation, they did not exhibit any symptoms suggestive of typical Rett syndrome (Table 1). Case 2 patient had nonspecific symptoms such as irritability, abnormal sleep patterns, and hypersensitivity to external stimuli, but these symptoms were relieved by clonazepam. Case 3 patient had epilepsy, which required multiple anti-epileptic drugs, and his orolingual-dyskinesia was sustained until his latest follow-up. All 3 patients were affected in the corpus callosum and showed myelination delay with microcephalic features in varying degrees on their brain MRI (Supplemental Digital Content Table S1).
Table 1

Summary of clinical features and neurodevelopmental profiles.

Case 1Case 2Case 3
Age at first visit11 m7 m6 m
Birth history
 Gestational age40 wks39 wks40+4 wks
 Birth weight3.1 kg3.2 kg3.5 kg
 Mode of deliveryCesarean sectionSpontaneousSpontaneous
Anthropometric data
 Height80.4 cm (85 p)69.7 cm (85 p)68.4 cm (50 p)
 Body weight8.7 kg (50 p)6.8 kg (10 p)8.8 kg (75 p)
 Head circumference42 cm (<3 p)40 cm (<3 p)40 cm (< 3p)
FOXG1 mutation
 Nucleotide changec.761A > Cc.958delCc.506dup
 Amino acid changep.Tyr254Serp.Arg320Alafsp.Lys170Glnfs
 Inheritancede novode novode novo
 Type of mutationMissenseFrameshiftFrameshift
 ACMGLikely pathogenicPathogenicPathogenic
 Last follow-up60 m18 m56 m
Motor development
 Sitting13 m (unassisted)18 m (assisted)14 m (assisted)
 Walking alone24 mNoNo
 Functional hand use43 mNo14 m
Speech development
 Can speak words35 mNoNo
 Expressive speech43 mNoNo
Behavior
 Social interactions13 mPoor8 m (social smile)
 Eye contact11 m11 m9 m
 Abnormal sleep patternNoYesYes
Neurological feature
 EpilepsyNoNoFocal epilepsy
 Stereotypic/dyskinetic movementNoNoOrolingual dyskinesia
 SpasticityNoYes, lower legNo
 StrabismusNoNoYes
Summary of clinical features and neurodevelopmental profiles. The phenotypical variability of FOXG1 syndrome has been reported as being correlated with the type of mutation.[ Truncating mutations in the N-terminal domain and the forkhead domain have been associated with severe phenotypes, whereas truncating mutations affecting the C-terminal domain or missense variants in the forkhead domain have been associated with favorable developmental milestones and brain abnormalities.[ In case 1 of our study, the patient with a novel missense mutation in the forkhead domain, c.761A > C (p.Tyr254Ser), had a better outcome and milder brain abnormalities than the other 2 patients with a truncating mutation in the groucho binding domain site, c.958delC (p.Arg320Alafs), or N-terminal domain, c.506dup (p.Lys170Glnfs). Interestingly, we found that all 3 patients were affected by hypoplastic olfactory bulbs in varying degrees with rather preserved olfactory sulci. The absence of recognizable olfactory epithelium, bulbs or vomeronasal organs was also observed in Foxg1 knock-out mice at older embryo stages.[ Therefore, hypoplastic olfactory bulbs may be another new phenotype suggestive of FOXG1 syndrome. However, the development of any clinical signs or symptoms related to olfactory bulb hypoplasia, such as hyposmia, anosmia, and parosmia, cannot be assessed due to due to their language and cognitive deficits. As the follow-up periods for our patients were short, we reviewed the clinical outcomes of nine previously reported adolescent or adult patients aged over 12 years.[ Unfortunately, all these patients showed persistent microcephaly, epilepsy, and movement disorders, and most of them could not achieve unassisted walking (9/9, 100%), functional hand use (4/6, 66.6%), expressive speech (8/8, 100%), or social interaction (3/8, 37.5%) (Table 2).
Table 2

Clinical summary of previously reported adolescent and adult patients with FOXG1 mutations.

AgeSexMutation typeMicrocephalySittingWalkingFunctional hand useSpeechSocial interactionSeizureMovementOthers
Arini et al[16]22 yMc.765G > A p.Trp255X + + + + Arrhythmic breathing
Mencarelli et al[4]13 y 2 mFc.681C > G; p.Asn227Lys + N/A N/A N/A + + Scoliosis
Phillipe et al[17]22 yFc.924A > G p.Trp308X + N/A + + +
Seltzer et al[12]16 y 3 mFc.460dupG p.Glu154Glyfs∗301+N/A + +
13 y 9 mMc.577G > A p.Ala193Thr + N/A + + + +
25 y 10 mFc.460dupG p.Glu154Glyfs∗301 + N/A +/− + +
22 yMc.460dupG p.Glu154Glyfs∗301 + N/A + +/− + +
Cellini et al[10]17 yFc.298delC; p.Gln100Serfs∗92 + N/A N/A + + Facial dysmorphism
Wong et al[3]17.3 yN/Ac. 250delC p.Gln86Argfs∗106 + + N/AN/A + +

N/A = not available.

Clinical summary of previously reported adolescent and adult patients with FOXG1 mutations. N/A = not available. This is the first report of FOXG1 syndrome in a Korean population, which accounts for 2% (3 of 145 patients) in our patient cohort with developmental delay and/or hypotonia. Early-onset axial hypotonia with microcephaly and brain MRI findings related to telencephalon development (such as callosal anomaly, decreased frontal volume, fornix thickening, and hypoplastic olfactory bulbs) were distinctive features of FOXG1 syndrome, and phenotypic severity was associated with the type of FOXG1 mutation. Our report contributes to further understanding this extremely rare genetic condition in the clinical and genetic perspectives.

Author contributions

Conceptualization: Han Na Jang, Beom Hee Lee, Mi-Sun Yum. Data curation: Ah Young Jung. Formal analysis: Taeho Kim, Ah Young Jung. Funding acquisition: Beom Hee Lee. Methodology: Han Na Jang. Resources: Taeho Kim, Ah Young Jung. Supervision: Tae-Sung Ko. Writing – original draft: Han Na Jang. Writing – review & editing: Han Na Jang, Beom Hee Lee, Mi-Sun Yum.
  17 in total

1.  Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females.

Authors:  C Philippe; D Amsallem; C Francannet; L Lambert; A Saunier; F Verneau; P Jonveaux
Journal:  J Med Genet       Date:  2009-06-29       Impact factor: 6.318

2.  Novel FOXG1 mutations associated with the congenital variant of Rett syndrome.

Authors:  M A Mencarelli; A Spanhol-Rosseto; R Artuso; D Rondinella; R De Filippis; N Bahi-Buisson; J Nectoux; R Rubinsztajn; T Bienvenu; A Moncla; B Chabrol; L Villard; Z Krumina; J Armstrong; A Roche; M Pineda; E Gak; F Mari; F Ariani; A Renieri
Journal:  J Med Genet       Date:  2009-07-02       Impact factor: 6.318

3.  Foxg1 is required for development of the vertebrate olfactory system.

Authors:  Cynthia D Duggan; Shannon DeMaria; Ariane Baudhuin; David Stafford; John Ngai
Journal:  J Neurosci       Date:  2008-05-14       Impact factor: 6.167

4.  Disruption of Foxg1 expression by knock-in of cre recombinase: effects on the development of the mouse telencephalon.

Authors:  K L Eagleson; L J Schlueter McFadyen-Ketchum; E T Ahrens; P H Mills; M D Does; J Nickols; P Levitt
Journal:  Neuroscience       Date:  2007-07-19       Impact factor: 3.590

5.  FOXG1 syndrome: genotype-phenotype association in 83 patients with FOXG1 variants.

Authors:  Diana Mitter; Milka Pringsheim; Marc Kaulisch; Kim Sarah Plümacher; Simone Schröder; Rita Warthemann; Rami Abou Jamra; Martina Baethmann; Thomas Bast; Hans-Martin Büttel; Julie S Cohen; Elizabeth Conover; Carolina Courage; Angelika Eger; Ali Fatemi; Theresa A Grebe; Natalie S Hauser; Wolfram Heinritz; Katherine L Helbig; Marion Heruth; Dagmar Huhle; Karen Höft; Stephanie Karch; Gerhard Kluger; G Christoph Korenke; Johannes R Lemke; Richard E Lutz; Steffi Patzer; Isabelle Prehl; Konstanze Hoertnagel; Keri Ramsey; Tina Rating; Angelika Rieß; Luis Rohena; Mareike Schimmel; Rachel Westman; Frank-Martin Zech; Barbara Zoll; Dörthe Malzahn; Birgit Zirn; Knut Brockmann
Journal:  Genet Med       Date:  2017-06-29       Impact factor: 8.822

6.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

7.  Delineating FOXG1 syndrome: From congenital microcephaly to hyperkinetic encephalopathy.

Authors:  Nancy Vegas; Mara Cavallin; Camille Maillard; Nathalie Boddaert; Joseph Toulouse; Elise Schaefer; Tally Lerman-Sagie; Dorit Lev; Barth Magalie; Sébastien Moutton; Eric Haan; Bertrand Isidor; Delphine Heron; Mathieu Milh; Stéphane Rondeau; Caroline Michot; Stephanie Valence; Sabrina Wagner; Marie Hully; Cyril Mignot; Alice Masurel; Alexandre Datta; Sylvie Odent; Mathilde Nizon; Leila Lazaro; Marie Vincent; Benjamin Cogné; Anne Marie Guerrot; Stéphanie Arpin; Jean Michel Pedespan; Isabelle Caubel; Benedicte Pontier; Baptiste Troude; Francois Rivier; Christophe Philippe; Thierry Bienvenu; Marie-Aude Spitz; Amandine Bery; Nadia Bahi-Buisson
Journal:  Neurol Genet       Date:  2018-11-07

8.  Structural brain anomalies in patients with FOXG1 syndrome and in Foxg1+/- mice.

Authors:  Milka Pringsheim; Diana Mitter; Simone Schröder; Rita Warthemann; Kim Plümacher; Gerhard Kluger; Martina Baethmann; Thomas Bast; Sarah Braun; Hans-Martin Büttel; Elizabeth Conover; Carolina Courage; Alexandre N Datta; Angelika Eger; Theresa A Grebe; Annette Hasse-Wittmer; Marion Heruth; Karen Höft; Angela M Kaindl; Stephanie Karch; Torsten Kautzky; Georg C Korenke; Bernd Kruse; Richard E Lutz; Heymut Omran; Steffi Patzer; Heike Philippi; Keri Ramsey; Tina Rating; Angelika Rieß; Mareike Schimmel; Rachel Westman; Frank-Martin Zech; Birgit Zirn; Pauline A Ulmke; Godwin Sokpor; Tran Tuoc; Andreas Leha; Martin Staudt; Knut Brockmann
Journal:  Ann Clin Transl Neurol       Date:  2019-03-03       Impact factor: 4.511

Review 9.  FOXG1-Related Syndrome: From Clinical to Molecular Genetics and Pathogenic Mechanisms.

Authors:  Lee-Chin Wong; Shekhar Singh; Hsin-Pei Wang; Chia-Jui Hsu; Su-Ching Hu; Wang-Tso Lee
Journal:  Int J Mol Sci       Date:  2019-08-26       Impact factor: 5.923

10.  Cognition and Evolution of Movement Disorders of FOXG1-Related Syndrome.

Authors:  Lee-Chin Wong; Yen-Tzu Wu; Chia-Jui Hsu; Wen-Chin Weng; Wen-Che Tsai; Wang-Tso Lee
Journal:  Front Neurol       Date:  2019-06-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.